Synthesis and in vitro structure-activity relationship of 13-tert-butyl-ergoline derivatives as 5-HT1A receptor ligands
- 31 October 1997
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 32 (10) , 795-804
- https://doi.org/10.1016/s0223-5234(99)80065-8
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- CabergolineDrugs, 1995
- 5-Hydroxytryptamine Antagonistic Effects of ICI 169,369, ICI 170,809 and Methysergide in Human Temporal and Cerebral ArteriesBasic & Clinical Pharmacology & Toxicology, 1991
- Synthèse et activité inhibitrice sur la nidation d'une nouvelle classe de dérivés de l'ergolineEuropean Journal of Medicinal Chemistry, 1989
- (8.beta.)-Ergoline-8-carboxylic acid cycloalkyl esters as serotonin antagonists: structure-activity studyJournal of Medicinal Chemistry, 1988
- 5-HT1A receptor-related anxiolyticsTrends in Pharmacological Sciences, 1987
- Resolved monophenolic 2-aminotetralins and 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines: structural and stereochemical considerations for centrally acting pre- and postsynaptic dopamine-receptor agonistsJournal of Medicinal Chemistry, 1985
- Changing concepts of the biochemical action of the anxioselective drug, buspironeDrug Development Research, 1984
- Methylthio activating groups in the synthesis of isoquinolinesJournal of the Chemical Society, Chemical Communications, 1984
- Effects of (8β)-8-[(Methylthio)methyl]-6-propylergoline on dopaminergic function and brain dopamine turnover in ratsLife Sciences, 1979
- Structure-activity relationship of various acyl derivatives of 6-methyl-8β-aminomethyl-10α-ergoline (dihydrolysergamine)Cellular and Molecular Life Sciences, 1968